UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 22, 2004
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
-----------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
--------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
1
Item 7.01. Regulation FD Disclosure.
On November 22, 2004, Ultralife Batteries, Inc. (the "Company") announced
the receipt of an order valued at approximately $2.2 million from the U. S.
Defense Department for its BA-5372/U military battery. The Company's press
release is attached as Exhibit 99.1 to this Form 8-K, and the information set
forth therein is furnished under item 7.01.
Item 9.01. Financial Statements, Pro Forma Financials and Exhibits.
(c) Exhibits.
99.1 Press Release dated November 22, 2004
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: November 22, 2004 By: /s/ Peter F. Comerford
_________________________
Peter F. Comerford
Vice President Administration & General
Counsel
2
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated November 22, 2004
3
Exhibit 99.1
Ultralife Batteries, Inc. Receives $2.2 Million U.S. Army Battery Order
NEWARK, N.Y.--(BUSINESS WIRE)--Nov. 22, 2004--Ultralife Batteries,
Inc. (NASDAQ: ULBI) has received an order valued at approximately $2.2
million from the U.S. Defense Department for its BA-5372/U military
battery. The order represents another release under Ultralife's Next
Gen II Small Cylindrical battery contract. Deliveries against the new
release are expected to begin by the end of 2005.
John D. Kavazanjian, Ultralife's president and chief executive
officer, said, "We have been supplying this important battery under a
number of contracts for 10 years and have increased production due to
its sustained high demand. This latest order illustrates the strength
of the overall demand for military batteries, since the BA-5372 is
used in the same radio systems as our BA-5390 battery."
NextGen II is the U.S. Army's five-year battery procurement
strategy. Phase II of this program included production contracts
awarded to provide three types of primary (non-rechargeable)
lithium-manganese dioxide batteries. The three battery types -
BA-5372/U, BA-5367/U and BA-5368/U - comprise the Small Cylindrical
Cell Lithium Manganese Dioxide Battery Group. A major objective of
this five-year procurement strategy is to establish and maintain a
domestic production base of a sufficient capacity to timely meet
peacetime demands and have the ability to surge quickly to meet
deployment demands.
The BA-5372/U battery is used for memory backup primarily for the
AN/PRC-119 MANPACK Single Channel Ground and Airborne Radio System
(SINCGARS), and in numerous other applications including encryption
and cryptographic devices, and the Patriot Missile System.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of
standard and customized lithium primary (non-rechargeable), lithium
ion and lithium polymer rechargeable batteries. Ultralife's
high-energy batteries use advanced lithium technology and are used in
military, industrial and consumer portable electronic products.
Through its range of standard products and ability to customize for a
wide range of applications, Ultralife is able to provide the next
generation of battery solutions. OEM, retail and government customers
include Energizer, Kidde Safety, Philips Medical Systems, Radio Shack
and the national defense agencies of the United States and United
Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research
facilities are in Newark, New York, near Rochester. Ultralife (UK)
Ltd., a second manufacturing facility, is located in Abingdon, U.K.
Both facilities are ISO-9001 certified.
This press release contains forward-looking statements based on
current expectations that involve a number of risks and uncertainties.
The potential risks and uncertainties that could cause actual results
to differ materially include: loss of business with the U.S.
government, worsening global economic conditions, world events,
increased competitive environment and pricing pressures, disruptions
related to restructuring actions and delays. Further information on
these factors and other factors that could affect Ultralife's
financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form
10-K.
Detailed information on Ultralife is available at the Company's
web site, www.ultralifebatteries.com.
Ultralife(R) is a registered trademark Ultralife Batteries, Inc.
CONTACT: Ultralife Batteries, Inc.
Pete Comerford, 315-332-7100
pcomerford@ulbi.com
or
Investor Relations Contact:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com
or
Media Contact:
Lippert/Heilshorn & Associates, Inc.
Chenoa Taitt, 212-838-3777
ctaitt@lhai.com